Melin Özgün Geçer

Melin Özgün Geçer

Auto-generated profile, based on publicly available information

Melin Özgün Geçer

Department of Pathology, Bezmialem Vakıf University, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGMelin Özgün Geçer
Melin Özgün Geçer
GKGökhan KAYA
Gökhan KAYA
Non-segmental vitiligo (NSV) is a chronic autoimmune skin disease marked by melanocyte loss and depigmented macules. While clinical features are well recognized, immunohistological correlates such as Melan-A expression and CD8⁺ T-cell infiltration remain undercharacterized. To examine the clinical, histological, and immunohistochemical features of NSV, with a focus on their relationship to disease severity. In this prospective case-control study, 25 NSV patients and 25 matched healthy controls were evaluated using standardized scoring systems (VASI, VIDA, VETF, VETI). Biopsies from lesional, marginal, and normal skin underwent immunohistochemical staining for Melan-A and CD8⁺ T cells. Histopathological changes were graded using a structured scoring system. Lesional skin exhibited significant melanocyte loss (Melan-A⁺ median: 5 [IQR: 3–8]) and elevated CD8⁺ T-cell infiltration (median: 15 [10–18]) compared to controls (p < 0.001). Marginal zones showed intermediate values, indicating subclinical immune activation. CD8⁺ infiltration positively correlated with VASI (r = 0.53), while Melan-A expression showed a negative correlation (r = − 0.55). Both markers were independent predictors of disease severity. NSV exhibits a spatial immunohistological gradient, where melanocyte loss and CD8⁺ T-cell infiltration parallel clinical severity. The integration of immunophenotyping with clinical scoring provides a novel biomarker strategy for personalized therapy.

20 March 2016 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
DŞDilek Şakirahmet Şen
Dilek Şakirahmet Şen
AKAyşe Filiz Gökmen Karasu
Ayşe Filiz Gökmen Karasu
MGMelin Özgün Geçer
Melin Özgün Geçer
NKNimet Karadayı
Nimet Karadayı
EYElif Ablan Yamuç
Elif Ablan Yamuç
Ovarian metasteses are often mistaken for primary adenocarcinoma. Studies conducted in recent years have focused on a search for an immunohistochemical marker to aid the differential diagnosis primary and metastatic ovarian carcinoma. Our study objective was to study the usefulness of Wilms tumor 1 (WT 1) antigen in this context. The study was conducted at the pathology clinic of Lütfi Kırdar Training and Research Hospital. Deparaffinated blocks of 40 epithelial ovarian tumors, 40 colon adenocarcinomas, and 35 cases of omentum metastases were studied. Cytokeratin 7 (CK 7), cytokeratin 20 (CK 20), and WT 1 were applied to all specimens. All ovarian adenocarcinomas were stained with CK 7 (100%). Colorectal adenocarcinomas were stained positive with CK 20 in 87.5% of cases. Primary ovarian adenocarcinomas stained positive with WT 1 in 82.5% of the cases and none of the colorectal adenocarcinomas showed staining with WT 1 (0%). WT 1 can be used in conjuction with CK 7 in the differential diagnosis of ovarian carcinomas.

3 September 2023 in The European Research Journal
Verified
Journal Article
Open access
PDF file
MGMelin Gecer
Melin Gecer
NBNur Büyükpınarbaşılı
Nur Büyükpınarbaşılı
STSeval Turna
Seval Turna
MBMehmet Beşi̇roğlu
Mehmet Beşi̇roğlu
ZGZuhal Gucın
Zuhal Gucın
Objectives: Gastric carcinoma (GC) is the fourth most common cause of cancer-related tumor deaths worldwide. The prognostic significance of CD44, CD133 and human epidermal growth factor receptor 2 (HER2) expression in GC remains controversial. Therefore, we aimed to investigate the relationship of CD44, CD133 and HER2 expression with clinicopathological features in metastatic and non-metastatic GC patients. Methods: A total of 139 patients with GC (68 with metastasis, 71 without metastasis) diagnosed were retrospectively analyzed. CD44 and CD133 expression were determined by immunohistochemical method in all cases. In addition, HER2 overexpression of the tumor was evaluated in patients with metastatic GC. Results: The CD133 positivity rate was 90.6% (n = 126) when all cases were considered, and that for CD44 was 84.9% (n = 118). There was no difference in CD133 and CD44 positivity (intensity or density) rates and between the total scores of metastatic and non-metastatic patients with GC (p > 0.05). HER2 positivity in metastatic cases was detected in 49 (70.1%) patients by immunohistochemical method. No correlation was found between CD133 total score and age, tumor size or depth, and HER2 scores in metastatic or non-metastatic cases (p > 0.05). In the correlation analyzes performed with CD44 scores, only a borderline significant correlation was found between CD44 scores and tumor size (r:0.175; p = 0.047) in non-metastatic cases. Conclusions: We demonstrated associations between CD44/CD133 expression and histological grade in all patients, between CD44 and tumor size in non-metastatic patients, and between HER2 and intestinal type (Lauren) in metastatic patients. The results of this study need to be confirmed by multicenter studies including large case series.

15 October 2022
Verified
Book
Open access
PDF file
MGMelin Özgün Geçer
Melin Özgün Geçer
ZTZeynep Tosuner
Zeynep Tosuner
NSNurtaç Asa Sarıkaş
Nurtaç Asa Sarıkaş
HSHazal Taş Solak
Hazal Taş Solak
EBEmel Daşgın Bitlis
Emel Daşgın Bitlis
EÇEmel Dikicioğlu Çetin
Emel Dikicioğlu Çetin
Deri eki tümörleri nadir görülen ve birbirine benzeyen tümörler olduğundan tanılarının konması ve ayırıcı tanılarının yapılması genellikle zordur. Bu konuda ulaşılabilen Türkçe kaynakların da sınırlı olması nedeniyle bu kitabın oluşturulma sürecini başlattık. Amacımız , genç meslektaşlarımıza yönelik güncel bir kaynak oluşturmaya katkıda bulunmaktı. Kitabın oluşumunda tüm yazarlarımız ile birlikte uzun ve yorucu bir süreçte elimizden gelen çabayı göstermiş olmamıza rağmen; varsa eksikliklerimiz için affınıza sığınıyoruz. Pilar Kılıf Akantomu ve Dilate Por Nurtaç ASA SARIKAŞ Prolifere Pilar Tümör Hazal TAŞ SOLAK Trikilemmom Emel DAŞGIN BİTLİS Trikofoliküloma Meryem YÜVRÜK Trikoepitelyoma Tevhide Bilgen ÖZCAN Pilomatriksoma Fatma Gülçiçek AYRANCI Trikoblastom Begüm ÇALIM GÜRBÜZ Tuçe SÖYLEMEZ AKKURT Trikilemmal Karsinom Dilek YILMAZ Sebase Hiperplazi Cansu BENLİ IŞIK Sebase Adenom Cemile ÖZDEMİR Sebaseoma Ezgi HACIHASANOĞLU Nevüs Sebaseus Vildan ELİBOL Sebasöz Karsinom Begüm ÇALIM GÜRBÜZ Hidrokistoma ve Kistadenom Gamze KULDUK Özben YALÇIN Silindirom Rabia Burçin GİRGİN Spiradenom Nilsen YILDIRIM ERDOĞAN Spiradenomdan Kaynaklanan Malign Neoplazi/Malign Spiradenom Nilsen YILDIRIM ERDOĞAN Siringom Rabia Burçin GİRGİN Siringofibroadenom Rabia Burçin GİRGİN Siringokistadenoma Papilliferum Nilüfer GÜRSAN Kondroid Siringom Meryem YÜVRÜK Hidradenom Gamze KULDUK Tübüler Apokrin Adenom Selma ERDOĞAN DÜZCÜ Papiller Ekrin Adenom Selma ERDOĞAN DÜZCÜ Poroma Özben YALÇIN Dermal Duktus Tümörü Zeynep Betül ERDEM Hidradenoma Papilliferum Nilüfer GÜRSAN Mikrokistik Adneksiyal Karsinom Ayşe Gökçen SADE Primer Kutanöz Adenoid Kistik Karsinom Zeynep TOSUNER Porokarsinom Zeynep TOSUNER Kutanöz Apokrin Karsinom Vildan ELİBOL Primer Kutanöz Müsinöz Karsinom Zeynep TOSUNER Emel DİKİCİOĞLU ÇETİN Hidradenokarsinom Melin ÖZGÜN GEÇER Digital Papiller Adenokarsinom Melin ÖZGÜN GEÇER